Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Robert C. Hyzy, Lavannya M. Pandit et al.|The Lancet Respiratory Medicine|2022

Cited by 127